AstraZeneca pauses coronavirus vaccine trial, what does this mean for markets?

Ross J Burland FXStreet

It was earlier reported that the AstraZeneca Covid-19 vaccine trial was on hold over safety concern.

See here AstraZeneca Covid-19 vaccine trial on hold over safety concern – STAT News

To elaborate, discussions about early authorizations and reports about White House pressure to speed along a coronavirus vaccine have worried the public.

The latest reports that Drug giant AstraZeneca said Tuesday it had paused global trials of its coronavirus vaccine because of unexplained illness in one of the volunteers is a real spanner in the works for risk appetite.

Further information

The company is testing its vaccine, called the Oxford vaccine which markets had high hopes for.

However, the hold up vs the concerns about moving too fast is a cocktail of contradictions which is concerning on both sides of the coin.

Earlier Tuesday, AstraZeneca joined eight other companies in signing a pledge promising they would not seek premature government approval for any coronavirus vaccine which could help to alleviate concerns to an extent.

"We, the undersigned biopharmaceutical companies, want to make clear our on-going commitment to developing and testing potential vaccines for COVID-19 in accordance with high ethical standards and sound scientific principles," a statement read that was signed by the CEOs of AstraZeneca, BioNTech GlaxoSmithKline, Johnson & Johnson, Merck, Moderna, Novavax, Pfizer and Sanofi.

"We believe this pledge will help ensure public confidence in the rigorous scientific and regulatory process by which COVID-19 vaccines are evaluated and may ultimately be approved," they added.

Nevertheless, with the stock market in a rout and risk assets struggling, this vaccine news is another problematic area for markets to recover from and we are indeed seeing downside in Asia today.

Market update since the news

The Nikkei is down some 1.5%.

Australian stocks that had kicked off Wednesday in the negative zone, pulled down by the US equities, is now down over 2%.

The Hang Seng Index is down over 1% and the SSE Composite is down over 1% also.

Author

Ross J Burland

FXStreet

Ross J Burland, born in England, UK, is a sportsman at heart. He played Rugby and Judo for his county, Kent and the South East of England Rugby team.

GBP/USD gains traction above 1.3400 as markets bet on BoE rate hikes

The GBP/USD pair gathers strength to around 1.3430 during the Asian trading hours on Friday. The British Pound edges higher against the US Dollar on the UK government leadership transition and growing expectations of further Bank of England interest rate hikes.

EUR/USD nudges higher above 1.1400 as traders ramp up their bets on ECB hikes

The EUR/USD pair posts modest gains around 1.1430 during the early Asian session on Friday, bolstered by a softer US Dollar. The European Central Bank is grappling with elevated core inflation, forcing traders to price in more aggressive tightening despite mixed guidance from ECB officials.

Gold hovers below $4,150 amid subdued USD price action

Gold struggles to capitalize on the previous day's positive move, holding below $4,150 in the Asian session on Friday as traders await further developments surrounding the US-Iran saga. Less hawkish FOMC Minutes keep the US Dollar on the defensive and help cap any downside in the non-yielding yellow metal.

Stocks rise as chipmakers rally and Iran oil shock fears fade

Stocks found their footing because two different pressure valves opened at the same time. Oil eased as traders faded the worst-case Iran script, while chipmakers caught a separate gust of oxygen from inside the AI ecosystem itself. That distinction matters. Crude helped calm the macro room, but it was not the spark under semis.

Five sessions, one round trip: Why the whipsaw is exactly what Warsh ordered

Markets opened July with a December hike as the base case and spent five trading sessions unlearning and relearning it. A 57K payrolls print bled the tightening bets out of the strip; a re-shut Strait of Hormuz is pushing them back in. Wednesday's minutes from the June Federal Open Market Committee meeting landed mid-round-trip, describing a world that had already stopped existing.

Bye, forward guidance: How to trade when central banks choose silence

Central banks have spent years telling markets what might come next. Now, traders face the possibility that they say a lot less. From the Federal Reserve to the European Central Bank and the Bank of England, policymakers are pushing back against forward guidance.